Spectrophotometric quantification of dolutegravir based on redox reaction with Fe3+/1,10-phenanthroline
Open Access
- 30 November 2020
- journal article
- research article
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 6 (1) , 1-8
Abstract
Background: A simple and sensitive spectrophotometric method was developed for the quantitative measurement of dolutegravir in pure form and pharmaceutical formulation. The present method was based on redox reaction between dolutegravir and ferric chloride, which upon complexation with 1,10-phenanthroline formed an orange-colored complex that showed absorption maximum at 520.0 nm.Results: The developed method obeyed linearity in the concentration range of 40.00–140.00 μg/mL. The method was also validated as per International Council for Harmonization guidelines and the results were within acceptance values. The validated method was employed for the determination of dolutegravir in pharmaceutical dosage form and the percentage assay value was found to be 102.5, which is in agreement with its label claimed.Conclusion: The developed redox-based colorimetric method could be used in the routine quality control analysis of dolutegravir present in various pharmaceutical dosage forms.Keywords
This publication has 15 references indexed in Scilit:
- A new analytical method for determination of dolutegravir and rilpivirine in pharmaceutical formulations by RP-HPLC methodInternational Journal of Research In Pharmaceutical Chemistry and Analysis, 2019
- DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF DOLUTEGRAVIR AND RILPIVIRINE IN BULK AND PHARMACEUTICAL DOSAGE FORM AND ITS APPLICATION TO RAT PLASMAAsian Journal of Pharmaceutical and Clinical Research, 2019
- SIMULTANEOUS ESTIMATION OF LAMIVUDINE, ABACAVIR AND DOLUTEGRAVIR BY UPLC METHODInternational Journal of Applied Pharmaceutics, 2018
- A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV DetectionTherapeutic Drug Monitoring, 2016
- High-Performance Liquid Chromatographic and High-Performance Thin-Layer Chromatographic Method for Quantitative Estimation of Dolutegravir Sodium in Bulk Drug and Pharmaceutical Dosage FormScientia Pharmaceutica, 2016
- Simultaneous HPLC Method Development and Validation for Estimation of Lamivudine, Abacavir and Dolutegravir in Combined Dosage Form with their Stability StudiesAsian Journal of Chemistry, 2016
- Development and validation of stability-indicating HPLC method for simeltaneous determination of Lamivudine, Tenofovir, and Dolutegravir in bulk and their tablet dosage formFuture Journal of Pharmaceutical Sciences, 2015
- Mecanismo de acción, farmacología e interacciones de dolutegravirEnfermedades Infecciosas y Microbiología Clínica, 2015
- A sensitive HPLC–MS/MS method for the determination of dolutegravir in human plasmaJournal of Chromatography B, 2014
- Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2010